NASDAQ:GALT Galectin Therapeutics (GALT) Insider Trading & Ownership $1.91 +0.01 (+0.49%) (As of 03:30 PM ET) Add Compare Share Share Today's Range$1.85▼$1.9550-Day Range$1.38▼$1.9752-Week Range$1.02▼$2.47Volume32,324 shsAverage Volume69,692 shsMarket Capitalization$113.53 millionP/E RatioN/ADividend YieldN/APrice Target$11.00 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage44.70%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$26,793.42Number OfInsiders Selling(Last 12 Months)0 Get GALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GALT Insider Buying and Selling by Quarter Galectin Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/19/2023Kary EldredDirectorBuy1,598$1.79$2,860.42 2/21/2023Kary EldredDirectorBuy1,000$1.59$1,590.00 2/16/2023Joel LewisCEOBuy1,000$1.52$1,520.00 1/25/2023Kary EldredDirectorBuy1,300$1.11$1,443.00 11/17/2022Jack W CallicuttCFOBuy4,000$1.32$5,280.00 10/28/2022Kevin D FreemanDirectorBuy10,000$1.41$14,100.00 (Data available from 1/1/2013 forward) GALT Insider Trading Activity - Frequently Asked Questions Who is on Galectin Therapeutics's Insider Roster? The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Gilbert F Amelio, Jack W Callicutt, Joel Lewis, Kary Eldred, Kevin D Freeman, and Richard A Jr. Zordani. Learn more on insiders at GALT. What percentage of Galectin Therapeutics stock is owned by insiders? 44.70% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings. Which Galectin Therapeutics insiders have been buying company stock? The following insiders have purchased GALT shares in the last 24 months: Elissa J Schwartz ($2,000.00), Jack W Callicutt ($5,280.00), Joel Lewis ($1,520.00), Kary Eldred ($5,893.42), Kevin D Freeman ($73,630.00), and Richard A Jr. Zordani ($30,600.00). How much insider buying is happening at Galectin Therapeutics? Insiders have purchased a total of 61,898 GALT shares in the last 24 months for a total of $118,923.42 bought. Which Galectin Therapeutics insiders have been selling company stock? The following insider sold GALT shares in the last 24 months: Fund L.P. 10X ($167,500.00). How much insider selling is happening at Galectin Therapeutics? Insiders have sold a total of 60,000 Galectin Therapeutics shares in the last 24 months for a total of $167,500.00 sold. More Insider Trading Tools from MarketBeat Related Companies: DiaMedica Therapeutics Insider Transactions Oramed Pharmaceuticals Insider Transactions Greenwich LifeSciences Insider Transactions Reviva Pharmaceuticals Insider Transactions Anixa Biosciences Insider Transactions Cue Biopharma Insider Transactions BioVie Insider Transactions Cara Therapeutics Insider Transactions Theseus Pharmaceuticals Insider Transactions Applied Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:GALT) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.